[1]王 田 张 莹.AChR胸腺中异位表达异常导致MG发病的研究[J].三才期刊采编系统演示平台,2015,1期(04):253-255.[doi:10.3969/j.issn.1007-0478.2015.04.019]
点击复制

AChR胸腺中异位表达异常导致MG发病的研究
分享到:

《三才期刊采编系统演示平台》[ISSN:1008-0341/CN:37-1280/R]

卷:
第1期
期数:
2015年04期
页码:
253-255
栏目:
综述
出版日期:
2015-12-31

文章信息/Info

文章编号:
1007-0478(2015)04-0253-03
作者:
王 田 张 莹
150086 哈尔滨医科大学附属第二医院神经内科二病房[王 田 张 莹(通信作者)]
分类号:
R746.1
DOI:
10.3969/j.issn.1007-0478.2015.04.019
文献标志码:
A

参考文献/References:

1 Levinson AI, Song D, Gaulton G, et al. The intrathymic pathogenesis of myasthenia gravis. Clin Immunol, 2004, 11(3/4):215-220.
2 Garchon HJ. Genetics of autoimmune myasthenia gravis, a model for antibody-mediated autoimmunity in man. J Autoimmun, 2003, 21(2):105-110.
3 Vincent A. Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol, 2002,2(10):797-804.
4 Zshotiyi Z, Kambouris ME, Patrinos GP, et al. Recent advances in genetic predisposition of myasthenia gravis. Biomed Res Int, 2013, 13(10):1-9.
5 Grob D, Brunner N, Namba T, et al. Lifetime course of myasthenia gravis. Muscle Nerve,2008,37(2):141-149.
6 Giraud M, Taubert R, Vandiedonck C,et al. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus. Nature,2007, 448(7156):934-937.
7 Derbinski J, Schulte A, Kyewski B,et al. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol, 2001, 2(11):1032-1039.
8 Takahama Y. Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol, 2006,6(2):127-135.
9 Starr TK, Jameson SC, Hogquist KA. Positive and negative selection of T cells. Annu Rev Immunol, 2003, 21(10):139-176.
10 Sheng JR, Li LC, Prabhakar BS, et al. Acetylcholine receptor-αsubmit expression in myasthenia gravis: a role for the autoantigen in pathogenesisi. Muscle Nerve, 2009, 40(2):279-286.
11 Heckmann JM, Morrison KE, Emeryk-Szajewska B, et al. Human muscle acetylcholine receptor alpha-subunit gene(CHRNA1)association with autoimmune myasthenia gravis in black, mixed-ancestry and caucasian subjects. J Autoimmun, 1996, 9(2):175-180.
12 蒋建明. 重症肌无力的研究历程与现状. 中国神经科学杂志,2002,18(1):473-475.
13 Djabrii F, Caillat-Zucman S, Gajdos P, et al. Association of the AChRα-subunit gene(CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. J Autoimmun, 1997, 10(4):407-413.
14 Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J CLIN INVEST, 2006, 116(11):2843-2852.
15 Gomez AM, Van Den Broeck J, Vrolix K, et al. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Autoimmunity, 2010, 43(5-6):353-370.
16 Scarpino S, Di Napoli A, Stoppacciaro A, et al. Expression of autoimmune regulator gene(AIRE)and T regulatory cells in human thymomas. Clin Exp Immunol., 2007, 149(3):504-512.
17 Aricha R, Feferman T, Scott HS,et al. The susceptibility of Aire(-/-)mice to experimental myasthenia gravis involves alterations in regulatory T cells. J Autoimmun, 2011, 36(1):16-24.
18 Heino M, Peterson P, Kudoh J, et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun, 1999, 257(3):821-825.

备注/Memo

备注/Memo:
2015-02-06收稿
基金项目:哈尔滨市科技创新人才研究专项资金项目(青年后备人才)资助编号为(2014RFQGJ006)
更新日期/Last Update: 2015-08-30